Pharmaceutical Sector Q4 Earnings Mixed; XPH ETF Posts 29% One-Year Return
Apr 29, 2026
Q4 earnings were mixed across 17 tracked pharmaceutical companies. Elanco and ANI Pharmaceuticals beat revenue estimates, while Corcept and Amphastar missed. The XPH pharma ETF posted a 29% one-year return but significantly lagged the S&P 500 over five and ten years.